Ligand profile
60N
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_1079 — metallo-beta-lactamase superfamily protein
Identifiers
Database identifiers and provenance.
- Ligand ID
60N- PDB
5hh6- UniProt (similar protein)
P52700- Target protein
- VK055_1079
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 128.0
- −1 ≤ LogP ≤ 5 -0.05
- MW ≤ 500 Da 233.1
- LogP ≤ 5 -0.05
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 128.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(nc(c1)C(=O)O)[C@@H](O)P(=O)(O)Oc1cc(nc(c1)C(=O)O)[C@@H](O)P(=O)(O)O
InChI=1S/C7H8NO6P/c9-6(10)4-2-1-3-5(8-4)7(11)15(12,13)14/h1-3,7,11H,(H,9,10)(H2,12,13,14)/t7-/m0/s1InChI=1S/C7H8NO6P/c9-6(10)4-2-1-3-5(8-4)7(11)15(12,13)14/h1-3,7,11H,(H,9,10)(H2,12,13,14)/t7-/m0/s1
BMLFSBIYIPWZDN-ZETCQYMHSA-NBMLFSBIYIPWZDN-ZETCQYMHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00753
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 60N →
- PDB RCSB structure 5hh6 →
- UniProt UniProt P52700 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “60N”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1079.
PDB 18
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 37
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).